Published by ChinaMNC · Taicang

China's Health-System Priorities: What Foreign Founders Should Know Before Setting Up

A practical briefing for foreign founders on the direction of China's health policy, drawn from official reporting on the Healthy China initiative, with pointers on where the priorities touch company registration and operations.

Why health policy belongs on a founder's checklist

China's official reporting on the Healthy China initiative describes health as a precondition for economic and social development and a marker of national strength. For a foreign founder registering or operating a company in China, that framing matters practically: health priorities shape public spending, local government agendas, regulated sectors and hiring expectations. This briefing summarizes what the official source says and translates it into points to watch.

The policy timeline in brief

The source traces a sequence of decisions:

• 2016: A national health conference set the current health work guidelines, shifting the focus from treating disease toward people-centered health, followed by the Healthy China 2030 blueprint.
• 2019: The Basic Medical Health and Promotion Law was promulgated, described as the first foundational, comprehensive law in the health field.
• Ongoing: Reform of the pharmaceutical and healthcare system, stronger public health infrastructure, health-focused poverty alleviation, and a national strategy for an aging population.

The source states that China has built the world's largest systems for medical services, traditional medicine, disease prevention and control, and medical security.

Outcomes the source reports

The article lists several indicators. Founders should treat these as the government's own reported figures, not independently verified data:

• Average life expectancy rose to 79.25 years in 2025, with major health indicators described as leading among upper-middle-income countries and countries with populations over 100 million.
• The infant mortality rate fell to 3.8 per thousand, and the maternal mortality rate to 13.4 per 100,000; the WHO is cited as listing China among high-performing countries for maternal and child health.
• Premature mortality from major chronic diseases fell to 13.8%.
• Malaria was eliminated, and China entered the low-to-mid tuberculosis prevalence group for the first time.
• Resident health literacy reached 33.69%.
• Student myopia rates fell for five consecutive years, reaching 49.9% in 2025, a cumulative drop of 3.7 percentage points from 2018.
• Personal health spending fell to 27.1% of total health expenditure.

Grassroots and rural care: a market signal

The source emphasizes moving medical resources downward to local levels. It cites a township health center on an island in Zhenjiang, Jiangsu, equipped with modern devices and visited periodically by doctors from higher-level hospitals. It also cites guidance given in 2020 in Pingli County, Shaanxi, that rural areas should use remote consultation to balance resources.

By the source's account, more than 90% of residents can reach nearby medical services within 15 minutes, and grassroots institutions handle over half of national patient visits. County-level integrated medical communities are being built in 2,199 counties, and 125 national regional medical centers are supported, with 75% located in central and western regions where quality resources are thinner.

Practical reading: If your business touches medical devices, digital health, diagnostics, elder care or distribution, official attention is directed toward county-level and grassroots capacity, not only top-tier urban hospitals. That is where public procurement and pilot programs are described as concentrating.

Reform lessons and cost control

The source describes the Sanming reform in Fujian, where drug prices fell, reimbursement rose and patient convenience improved, with the model replicated nationally. Measures listed include ending drug markups, centralized volume-based procurement of drugs and consumables, service-price reform, tiered diagnosis, and payment-method reform.

It also states that public welfare must remain the flag of the medical and health sector, and that a fully marketized or commercialized path is rejected. For founders, the implication is that healthcare provision and insurance are not open markets in the ordinary sense; adjacent commercial activity is more likely to be viable than direct operation of core medical services.

Traditional medicine and workforce

The source reports 42,200 traditional medicine clinics in grassroots institutions, with 80% of township health centers and community health service centers able to apply appropriate traditional techniques. It also stresses respect for health workers.

Foreign founders exploring wellness, rehabilitation or traditional-medicine-adjacent products should expect the sector to be regulated and tied to licensed practitioners.

Checklist before you register

• Classify your activity. Determine whether your product or service counts as a medical device, drug, health service or general consumer good; the last is far easier to register.
• Watch local pilots. County-level medical communities and regional medical centers are the stated focus of resource allocation; local commerce and health authorities publish relevant notices.
• Budget for procurement reality. Centralized volume-based purchasing and cost control are central to reform; price expectations should reflect this.
• Do not assume commercialization of core care. The source explicitly rejects a fully commercial path for medical services.
• Respect staffing rules. Traditional medicine and clinical services require licensed personnel.
• Verify current rules locally. Registration, licensing and sector rules change; confirm with the local market regulation and health authorities or qualified counsel.

Bottom line

The official narrative positions health as a foundation of national development, with money and attention flowing to prevention, grassroots capacity, cost control and traditional medicine. Foreign founders should read this as a map of public priorities rather than a market forecast, and should confirm all registration and licensing questions with local authorities before committing capital.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.